ArticleEuropean journal of nutrition2026
Sugar- and artificially sweetened beverages consumption, body weight, and eating disorders symptoms: findings from a Danish cohort from childhood to early adulthood.
Article in European journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeThis study assessed the associations between the consumption of sugar- (SSBs) and artificially sweetened beverages (ASBs) and body weight from childhood through adolescence. Moreover, we examined the relationship between childhood weight status and the joint associations between SSBs and ASBs and weight status on eating disorders (ED) symptoms in early adulthood.
methodsThis study used the Danish National Birth Cohort (DNBC) at the 11- and 18-year follow-up (DNBC-11 and DNBC-18). At age 11, children reported their consumption of SSBs and ASBs. Body weight was assessed using BMI based on information from DNBC-11 and DNBC-18. ED were derived from self-reported symptoms and national health registers. Multivariable logistic regression models were used.
resultsChildren with a higher consumption of SSBs and ASBs at age 11 had higher odds of overweight or obesity at age 11 (OR: 1.43, 95%CI 1.24–1.64) and age 18 (OR: 1.20, 95%CI 1.00–1.43). Children with overweight (OR: 1.36, 95%CI 1.08–1.70) and obesity (OR: 2.08, 95%CI 1.09–3.97) at age 11 had higher odds of ED symptoms at age 18. Children with overweight or obesity who consumed SSBs and ASBs below and above the median at age 11 had higher odds of ED symptoms at age 18 than those with underweight or normal weight and a consumption below the median (OR: 1.41, 95%CI 1.04–1.92 and OR: 1.50, 95%CI 1.12–2.00, respectively).
conclusionsSSBs and ASBs consumption during childhood was associated with overweight and obesity in the short- and long-term. Childhood overweight or obesity was also related to later ED symptoms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.